Form EFFECT Sonnet BioTherapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001493152-25-026924 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Court Upholds Lara's Endorsement Of Insurer Discrimination, Says Consumer Watchdog
- Stellus Private Credit BDC Announces $0.31 Third Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.1033 in July, August, and September 2026
- LiLi Tile Adds AI-Powered Pattern Generation to Custom Tile Design Platform, Allowing Designers and Homeowners to Create Original Handmade Cement Tile Designs
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
